Text Size

Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients

This study has been completed.
Sponsor:
Information provided by:
State University of New York - Downstate Medical Center
ClinicalTrials.gov Identifier:
NCT00433134
First received: February 7, 2007
Last updated: April 23, 2009
Last verified: April 2009
History of Changes
  Purpose

Goal:

To define the causes and issues associated with nonadherence in our population

Hypothesis:

There is a difference in the rates and patterns of adherence to transplant medications versus other medications also taken by transplant patients

Methods:

  1. A standardized interviewer-administered confidential survey exploring levels of adherence to transplant medications and other medications as well questionnaires on a variety of cognitive and other factors known to be associated with adherence.
  2. A brief review of demographics and pertinent laboratory information at the same encounter

Condition Intervention
Kidney Transplantation
Treatment Refusal
Patient Compliance
 Behavioral: Adherence

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Survey Investigation of Adherence to Immunosuppression and Other Medications Among Kidney Transplant Recipients at SUNY Downstate

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by State University of New York - Downstate Medical Center:

Estimated Enrollment: 100
Study Start Date: June 2006
Study Completion Date: June 2007
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Objectives:

  1. To determine the prevalence of nonadherence in our population
  2. To assess possible causes of nonadherence and correlate those causes with demographic information and clinical findings
  3. To assess for differences between adherence with immunosuppressive regime versus adherence with other medications (for hypertension, diabetes, hypercholesterolemia)

Methods:

  1. A standardized interviewer-administered confidential survey exploring levels of adherence to transplant medications and other medications as well questionnaires on a variety of cognitive and other factors known to be associated with adherence
  2. A brief review of demographics and pertinent laboratory information at the same encounter
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All renal transplant recipients with a working transplant who are currently attending the transplant clinic and who have been transplanted 6 months to 4.5 years ago are eligible. Patients are recruited at random from the transplant clinic waiting area

Exclusion Criteria:

  • Less than 6 months post-transplant
  • More than 4.5 years post transplant
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00433134

Locations
United States, New York
SUNY Downstate Medical Center
Brooklyn, New York, United States, 11203
Sponsors and Collaborators
State University of New York - Downstate Medical Center
Investigators
Principal Investigator: Mariana Markell, MD State University of New York - Downstate Medical Center
Principal Investigator: Sima Terebelo, MPH, RPA-C State University of New York - Downstate Medical Center
  More Information

No publications provided

Responsible Party: Mariana Markell, MD, SUNY Downstate MC
ClinicalTrials.gov Identifier: NCT00433134     History of Changes
Other Study ID Numbers: 06-093
Study First Received: February 7, 2007
Last Updated: April 23, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by State University of New York - Downstate Medical Center:
renal transplant recipient
adherence
compliance
immunosuppression

ClinicalTrials.gov processed this record on June 18, 2013